[HTML][HTML] Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis
S Svegliati Baroni, M Santillo… - … England Journal of …, 2006 - Mass Medical Soc
Background Systemic sclerosis (scleroderma) is characterized by immunologic abnormalities,
injury of endothelial cells, and tissue fibrosis. Abnormal oxidative stress has been …
injury of endothelial cells, and tissue fibrosis. Abnormal oxidative stress has been …
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up‐regulation of reactive oxygen species generation through the …
P Sambo, SS Baroni, M Luchetti… - Arthritis & …, 2001 - Wiley Online Library
Objective To explore the role of reactive oxygen species (ROS) in the in vitro activation of skin
fibroblasts from patients with systemic sclerosis (SSc). Methods Fibroblasts were obtained …
fibroblasts from patients with systemic sclerosis (SSc). Methods Fibroblasts were obtained …
Agonistic antibodies in systemic sclerosis
G Moroncini, SS Baroni, A Gabrielli - Immunology letters, 2018 - Elsevier
Systemic sclerosis (SSc) is characterized by microangiopathy, excessive fibrosis, and the
presence of circulating autoantibodies to several cellular and extracellular components. The …
presence of circulating autoantibodies to several cellular and extracellular components. The …
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients
…, G Pomponio, A Ferrarini, SS Baroni… - Mechanisms of ageing …, 2021 - Elsevier
Current COVID-19 pandemic poses an unprecedented threat to global health and healthcare
systems. The most amount of the death toll is accounted by old people affected by age-…
systems. The most amount of the death toll is accounted by old people affected by age-…
A reactive oxygen species–mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis
T Spadoni, S Svegliati Baroni, D Amico… - Arthritis & …, 2015 - Wiley Online Library
Objective Reactive oxygen species (ROS) contribute to the pathogenesis of fibrosis in systemic
sclerosis (SSc; scleroderma), and NADPH oxidase (NOX) is an important source of ROS. …
sclerosis (SSc; scleroderma), and NADPH oxidase (NOX) is an important source of ROS. …
[HTML][HTML] Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice
…, S Saccomanno, G Goteri, S Svegliati Baroni… - PLoS …, 2018 - journals.plos.org
Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with
different etiologies. Current therapy of ILD, especially those associated with connective tissue …
different etiologies. Current therapy of ILD, especially those associated with connective tissue …
Induction of Scleroderma Fibrosis in Skin‐Humanized Mice by Administration of Anti− Platelet‐Derived Growth Factor Receptor Agonistic Autoantibodies
…, M Jose Escamez, S Svegliati Baroni… - Arthritis & …, 2016 - Wiley Online Library
Objective To describe a skin–SCID mouse chimeric model of systemic sclerosis (SSc;
scleroderma) fibrosis based on engraftment of ex vivo–bioengineered skin using skin cells derived …
scleroderma) fibrosis based on engraftment of ex vivo–bioengineered skin using skin cells derived …
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality
…, G Pomponio, A Ferrarini, A Gabrielli, SS Baroni… - Mechanisms of Ageing …, 2022 - Elsevier
The stratification of mortality risk in COVID-19 patients remains extremely challenging for
physicians, especially in older patients. Innovative minimally invasive molecular biomarkers are …
physicians, especially in older patients. Innovative minimally invasive molecular biomarkers are …
[HTML][HTML] Putative functional pathogenic autoantibodies in systemic sclerosis
D Benfaremo, SS Baroni, L Manfredi… - European Journal of …, 2020 - ncbi.nlm.nih.gov
Systemic sclerosis (scleroderma, SSc) is a systemic disease characterized by vascular
lesions, fibrosis, and circulating autoantibodies. A complex interplay between innate and …
lesions, fibrosis, and circulating autoantibodies. A complex interplay between innate and …
[HTML][HTML] Screening and analysis of possible drugs binding to PDGFRα: A molecular modeling study
…, C Paolini, S Agarbati, S Svegliati Baroni… - International Journal of …, 2023 - mdpi.com
The platelet-derived growth factor receptor (PDGFR) is a membrane tyrosine kinase receptor
involved in several metabolic pathways, not only physiological but also pathological, as in …
involved in several metabolic pathways, not only physiological but also pathological, as in …
